A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration (NCT06161584)

🧪 Interventions in This Study

• Pegcetacoplan (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (34 Sites)

Showing the first 25 of 34 sites.

• California Retina Consultants (01-026) — Bakersfield, California
• Retina-Vitreous Associates Medical Group (01-020) — Beverly Hills, California
• Illinois Retina Associates (01-035) — Fullerton, California
• Retinal Consultants Medical Group Inc (01-008) — Modesto, California
• Retina Consultants San Diego Inc. (01-018) — Poway, California
• California Retina Consultants (01-027) — Santa Barbara, California
• Bay Area Retina Associates (01-005) — Walnut Creek, California
• Colorado Retina Associates, PLLC (01-011) — Lakewood, Colorado
• Retina Specialty Institute (01-019) — Pensacola, Florida
• South East Retina Center, PC (01-030) — Augusta, Georgia
• Georgia Retina (01-032) — Marietta, Georgia
• Illinois Retina Associates (01-037) — Oak Park, Illinois
• The Retina Care Center (01-023) — Baltimore, Maryland
• Cumberland Valley Retina Consultants, P.C. (01-002) — Hagerstown, Maryland
• Mid Atlantic Retina Specialist (01-029) — Hagerstown, Maryland
• Retina Consultants of Minnesota, PLLC (01-025) — Edina, Minnesota
• Mid Atlantic Retina Research (01-014) — Cherry Hill, New Jersey
• Mid Atlantic Retina (01-031) — Cherry Hill, New Jersey
• OCLI Research Department (01-007) — Oceanside, New York
• Long Island Vitreoretinal Consultants (01-013) — Westbury, New York
• Western Carolina Retinal Associates, PA (01-009) — Asheville, North Carolina
• Retina Associates of Cleveland, Inc. (01-017) — Cleveland, Ohio
• Retina Associates of Cleveland, Inc. (01-022) — Cleveland, Ohio
• Retina Associates of Cleveland, Inc. (01-016) — Youngstown, Ohio
• Mid Atlantic Retina (01-001) — Bethlehem, Pennsylvania

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Geographic Atrophy

• A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA) — Scottsdale, Arizona
• Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy — Phoenix, Arizona
• A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy — Gilbert, Arizona
• Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy — Phoenix, Arizona
• A Study in Adults With Geographic Atrophy — Bakersfield, California

Explore by condition: All Geographic Atrophy clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.